AstraZeneca cancer drug Calquence cost tumbles with PBS listing

The Advertiser

23 December 2023 - An AstraZeneca drug’s listing on the PBS from January 1 will see bills fall massively for people like Jen Wright.

It will be a very happy new year for some blood cancer patients such as Jen Wright with a new drug being listed on the Pharmaceutical Benefits Scheme from January 1, taking its cost from around $96,000 to a maximum of just $31.60.

Read The Advertiser article

Michael Wonder

Posted by:

Michael Wonder